vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and Third Coast Bancshares, Inc. (TCBX). Click either name above to swap in a different company.

Third Coast Bancshares, Inc. is the larger business by last-quarter revenue ($57.7M vs $40.7M, roughly 1.4× PETMED EXPRESS INC). Third Coast Bancshares, Inc. runs the higher net margin — 28.4% vs -26.0%, a 54.3% gap on every dollar of revenue. Over the past eight quarters, Third Coast Bancshares, Inc.'s revenue compounded faster (17.5% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Third Coast Bancshares, Inc. is a regional financial holding company headquartered in the U.S. Gulf Coast region. It provides a full suite of commercial and retail banking services including deposit products, business and consumer loans, mortgage services, and wealth management solutions, serving local small and medium-sized enterprises, individual consumers, and community clients across Texas and surrounding areas.

PETS vs TCBX — Head-to-Head

Bigger by revenue
TCBX
TCBX
1.4× larger
TCBX
$57.7M
$40.7M
PETS
Higher net margin
TCBX
TCBX
54.3% more per $
TCBX
28.4%
-26.0%
PETS
Faster 2-yr revenue CAGR
TCBX
TCBX
Annualised
TCBX
17.5%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
PETS
PETS
TCBX
TCBX
Revenue
$40.7M
$57.7M
Net Profit
$-10.6M
$16.4M
Gross Margin
23.3%
Operating Margin
-25.7%
Net Margin
-26.0%
28.4%
Revenue YoY
-23.3%
Net Profit YoY
-1392.6%
20.5%
EPS (diluted)
$-0.50
$0.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
TCBX
TCBX
Q1 26
$57.7M
Q4 25
$40.7M
$56.5M
Q3 25
$44.4M
$54.5M
Q2 25
$51.2M
$52.0M
Q1 25
$50.8M
$45.9M
Q4 24
$52.0M
$46.3M
Q3 24
$58.0M
$42.9M
Q2 24
$66.2M
$41.7M
Net Profit
PETS
PETS
TCBX
TCBX
Q1 26
$16.4M
Q4 25
$-10.6M
$17.9M
Q3 25
$-8.5M
$18.1M
Q2 25
$-34.2M
$16.7M
Q1 25
$-11.6M
$13.6M
Q4 24
$-707.0K
$13.7M
Q3 24
$2.3M
$12.8M
Q2 24
$3.8M
$10.8M
Gross Margin
PETS
PETS
TCBX
TCBX
Q1 26
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Operating Margin
PETS
PETS
TCBX
TCBX
Q1 26
Q4 25
-25.7%
38.1%
Q3 25
-18.9%
41.9%
Q2 25
-66.7%
40.5%
Q1 25
-11.9%
37.8%
Q4 24
-0.9%
38.7%
Q3 24
1.0%
37.9%
Q2 24
6.6%
34.1%
Net Margin
PETS
PETS
TCBX
TCBX
Q1 26
28.4%
Q4 25
-26.0%
31.7%
Q3 25
-19.2%
33.1%
Q2 25
-66.7%
32.2%
Q1 25
-22.9%
29.6%
Q4 24
-1.4%
29.7%
Q3 24
4.0%
29.8%
Q2 24
5.7%
25.9%
EPS (diluted)
PETS
PETS
TCBX
TCBX
Q1 26
$0.88
Q4 25
$-0.50
$1.02
Q3 25
$-0.41
$1.03
Q2 25
$-1.65
$0.96
Q1 25
$-0.56
$0.78
Q4 24
$-0.03
$0.80
Q3 24
$0.11
$0.74
Q2 24
$0.18
$0.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
TCBX
TCBX
Cash + ST InvestmentsLiquidity on hand
$26.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$32.8M
$650.5M
Total Assets
$88.0M
$6.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
TCBX
TCBX
Q1 26
Q4 25
$26.9M
$175.2M
Q3 25
$36.1M
$116.4M
Q2 25
$41.1M
$113.1M
Q1 25
$54.7M
$219.0M
Q4 24
$50.1M
$371.2M
Q3 24
$52.0M
$258.2M
Q2 24
$46.0M
$241.8M
Stockholders' Equity
PETS
PETS
TCBX
TCBX
Q1 26
$650.5M
Q4 25
$32.8M
$531.0M
Q3 25
$43.1M
$513.8M
Q2 25
$51.5M
$496.1M
Q1 25
$85.1M
$479.8M
Q4 24
$96.2M
$460.7M
Q3 24
$96.4M
$450.5M
Q2 24
$93.5M
$435.0M
Total Assets
PETS
PETS
TCBX
TCBX
Q1 26
$6.6B
Q4 25
$88.0M
$5.3B
Q3 25
$100.3M
$5.1B
Q2 25
$109.8M
$4.9B
Q1 25
$148.7M
$4.9B
Q4 24
$144.8M
$4.9B
Q3 24
$146.0M
$4.6B
Q2 24
$152.7M
$4.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
TCBX
TCBX
Operating Cash FlowLast quarter
$-9.2M
Free Cash FlowOCF − Capex
$-9.2M
FCF MarginFCF / Revenue
-22.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
TCBX
TCBX
Q1 26
Q4 25
$-9.2M
$50.8M
Q3 25
$-2.2M
$20.7M
Q2 25
$-12.3M
$13.9M
Q1 25
$7.0M
$10.5M
Q4 24
$-1.2M
$35.1M
Q3 24
$7.4M
$22.0M
Q2 24
$-8.5M
$7.3M
Free Cash Flow
PETS
PETS
TCBX
TCBX
Q1 26
Q4 25
$-9.2M
Q3 25
$-4.8M
Q2 25
$-13.6M
Q1 25
$4.6M
Q4 24
$-1.9M
$33.4M
Q3 24
$6.1M
Q2 24
$-9.2M
FCF Margin
PETS
PETS
TCBX
TCBX
Q1 26
Q4 25
-22.7%
Q3 25
-10.8%
Q2 25
-26.5%
Q1 25
9.1%
Q4 24
-3.7%
72.1%
Q3 24
10.6%
Q2 24
-13.9%
Capex Intensity
PETS
PETS
TCBX
TCBX
Q1 26
Q4 25
0.1%
Q3 25
5.9%
Q2 25
2.5%
Q1 25
4.7%
Q4 24
1.5%
3.8%
Q3 24
2.2%
Q2 24
1.0%
Cash Conversion
PETS
PETS
TCBX
TCBX
Q1 26
Q4 25
2.84×
Q3 25
1.15×
Q2 25
0.83×
Q1 25
0.77×
Q4 24
2.56×
Q3 24
3.18×
1.72×
Q2 24
-2.27×
0.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

TCBX
TCBX

Net Interest Income$53.6M93%
Noninterest Income$4.0M7%

Related Comparisons